approval
savePRALUENT (ALIROCUMAB) — FDA approval
community read0 votes
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalPRALUENT (ALIROCUMAB) — FDA approvalOct 9, 2025 · 357d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalMar 8, 2024 · 937d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021 · 2009d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021 · 2009d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalMar 10, 2020 · 2396d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2715d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2715d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalNov 6, 2018 · 2886d ago
comments(0)
5-min edit window · permanent after that